Browse the corpus

REFERENCES Blomström-Lundqvist C, Scheinman MM, Aliot EM, et al, “ACC/AHA/ESC Guidelines for the Management of Patients With Supraventricular Arrhythmias--Executive Summary. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias),” Circulation , 2003, 108(15):1871-909. [PubMed 14557344 ] Delacrétaz E, “Clinical Practice: Supraventricular Tachycardia,” N Engl J Med , 2006, 354(10):1039-51. [PubMed 16525141 ] Ellenbogen KA, Thames MD, DiMarco JP, et al, “Electrophysiological Effects of Adenosine in the Transplanted Human Heart. Evidence of Supersensitivity,” Circulation , 1990, 81(3):821-8. [PubMed 2306833 ] Field JM, Hazinski MF, Sayre MR, et al, “Part 1: Executive Summary: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care,” Circulation , 2010, 122 (18 Suppl 3):640-56. [PubMed 20956217 ] Fuster V, Ryden LE, Cannom DS, et al, “ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation),” J Am Coll Cardiol , 2006, 48(4):149-246. [PubMed 16908781 ] Harrison JK, Greenfield RA, and Wharton JM, “Acute Termination of Supraventricular Tachycardia by Adenosine During Pregnancy,” Am Heart J , 1992, 123(5):1386-8. [PubMed 1575160 ] Henzlova MJ, Cerqueira MD, Mahmarian JJ, et al, “Stress Protocols and Tracers,” J Nuc Cardiol , 2006, 13(6):e80-90. [PubMed 17174798 ] Kleinman ME, Chameides L, Schexnayder SM, et al, “Part 14: Pediatric Advanced Life Support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care,” Circulation , 2010, 122(18 Suppl 3):876-908. [PubMed 20956230 ] McIntosh-Yellin NL, Drew BJ, and Scheinman MM, “Safety and Efficacy of Central Intravenous Bolus Administration of Adenosine for Termination of Supraventricular Tachycardia,” J Am Coll Cardiol , 1993, 22(3):741-5. [PubMed 8354807 ]

Kleinman ME, Chameides L, Schexnayder SM, et al, “Part 14: Pediatric Advanced Life Support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care,” Circulation , 2010, 122(18 Suppl 3):876-908. [PubMed 20956230 ] McIntosh-Yellin NL, Drew BJ, and Scheinman MM, “Safety and Efficacy of Central Intravenous Bolus Administration of Adenosine for Termination of Supraventricular Tachycardia,” J Am Coll Cardiol , 1993, 22(3):741-5. [PubMed 8354807 ] McLaughlin VV, Archer SL, Badesch DB, et al, “ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension. A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association,” Circulation , 2009, 119(16):2250-94. [PubMed 19332472 ] Neumar RW, Otto CW, Link MS, et al, “Part 8: Adult Advanced Cardiovascular Life Support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care,” Circulation , 2010, 122(18 Suppl 3):729-67. Rich S, Kaufmann E, and Levy PS, “The Effect of High Doses of Calcium-channel Blockers on Survival in Primary Pulmonary Hypertension,” N Engl J Med, 1992, 327(2):76-81. [PubMed 1603139 ] Schrader BJ, Inbar S, Kaufmann L, et al, “Comparison of the Effects of Adenosine and Nifedipine in Pulmonary Hypertension,” J Am Coll Cardiol , 1992, 19(5):1060-4. [PubMed 1552096 ] Topic 9359 Version 42.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.4 - C21.36 Licensed to: Southeast Alabama Med Ctr | Support Tag: [1104-122.72.76.133-17F8E0A872-S244013.14]